InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,762.48
(
0.42%
)
US TECH 100
19,481.60
(
0.06%
)
Dow Jones
42,330.15
(
0.04%
)
Brent Oil
71.94
(
-0.07%
)
Bitcoin
63,308.50
(
-0.03%
)
Post# of 253260
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120519
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ThomasS post# 65061

Tuesday, 08/05/2008 7:46:23 AM

Tuesday, August 05, 2008 7:46:23 AM

Post# of 253260
VRUS – Data from the 500mg BID and 1500mg BID cohorts of this study were reported in April (#msg-28837612). What’s new in today’s PR are preliminary data from the 1000mg BID cohort. Data from a fourth cohort (1500mg BID in treatment-refractory gentotype-2/3) have not yet been reported.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up